Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

More UK pharmacy news

More news

  • Methods for small scale, point-of-use manufacture of drugs have now reached an advanced stage, delegates heard at the American Society of Health-System Pharmacists ‘midyear clinical meeting’

    Miniaturised drug production has role to play in emergencies, conference hearsSubscription

    Methods for small scale, point-of-use manufacture of drugs have now reached an advanced stage, delegates heard at the American Society of Health-System Pharmacists ‘midyear clinical meeting’ in New Orleans, Louisiana.

  • Event on pharmacists’ access to the electronic patient record hosted by the RPS. In the image, Kevin Barron, Gisela Stuart, Zafar Khan, Sandra Gidley, Victoria Borwick, Stephen Hammond

    Why shouldn't pharmacists have access to patient records?Subscription

    “Talk to your local MP and invite them to your pharmacy!” This was the advice given by Oliver Colvile, vice chair of the All-Party Pharmacy Group (APPG), at an evening of discussion hosted by the Royal Pharmaceutical Society (RPS) London Central Local Practice Forum at Portcullis House on 6 January 2016.

  • The Pharmacy Informatics Forum on 1 December 2015 highlighted the speed at which electronic prescribing is growing within UK hospitals. Pictured, Keith Farrar, clinical lead of the OPEN ePrescribing project for NHS England.

    Moving closer to a paperless NHSSubscription

    The Pharmacy Informatics Forum highlighted the speed at which electronic prescribing is growing within UK hospitals and how health professionals should approach the changes to get the best results.

  • Cyramza indication extendedSubscription

    The indication of Cyramza (ramucirumab; Eli Lilly), in combination with FOLFIRI (irinotecan, folinic acid, and 5‑fluorouracil), has been extended to include the treatment of adult patients with metastatic colorectal cancer with disease progression on or after prior therapy with bevacizumab, oxaliplatin and a fluoropyrimidine. In addition, Cyramza in combination with docetaxel is also indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung ...

  • Revolade for idiopathic ITPSubscription

    The indication of Revolade (eltrombopag; Novartis) has been extended to include adult chronic immune (idiopathic) thrombocytopenic purpura (ITP) patients who are refractory to other treatments (e.g. corticosteroids, immunoglobulins).

  • Desmopressin patient safety alertSubscription

    A patient safety alert has been issued by NHS England to raise awareness of the risk of severe dehydration and death caused by an omission or delay of desmopressin in patients with cranial diabetes insipidus. Following reports of patient safety incidents caused by an omission or delay in the provision of desmopressin, providers of NHS care are asked to consider if immediate action needs to be taken locally to raise awareness and reduce the risk of these incidents from occurring. The

  • NICE recommends nintedanibSubscription

    The National Insitute for Health and Care Excellence (NICE) has recommended nintedanib as an option for treating idiopathic pulmonary fibrosis if the person has between 50% and 80% of their predicted forced vital capacity (FVC); the company provides nintedanib with the discount agreed in the patient access scheme; and treatment is stopped if disease progresses (a confirmed decline in percent predicted FVC of 10% or more) in any 12‑month period. Further details can be found on the

  • NICE does not recommend ramucirumabSubscription

    The National Institute for Health and Care Excellence (NICE) has not recommended ramucirumab alone or with paclitaxel for advanced gastric cancer or gastro-oesophageal junction adenocarcinoma previously treated with chemotherapy. However, people whose treatment with ramucirumab was started before this guidance was published should be able to continue treatment until they and their clinician consider it appropriate to stop. Further details can be found on the

  • NICE recommends panobinostatSubscription

    The National Institute for Health and Care Excellence (NICE) has recommended panobinostat in combination with bortezomib and dexamethasone, within its marketing authorisation, as an option for treating multiple myeloma, that is, for “adult patients with relapsed and/or refractory multiple myeloma who have received at least two prior regimens including bortezomib and an immunomodulatory agent” when the company provides panobinostat with the discount agreed in the patient access scheme. ...

  • NICE recommends prostate cancer drugsSubscription

    The National Institute for Health and Care Excellence (NICE) has recommended Radium‑223 dichloride as an option for treating adults with hormone‑relapsed prostate cancer, symptomatic bone metastases and no known visceral metastases, if they have had treatment with docetaxel and the company ...

  • NICE recommends olaparibSubscription

    The National Institute for Health and Care Excellence (NICE) has recommended olaparib within its marketing authorisation as an option for treating adults with relapsed, platinum sensitive ovarian, fallopian tube or peritoneal cancer who have BRCA1 or BRCA2 mutations and whose disease has responded to platinum based chemotherapy if they have had three or more courses of platinum based chemotherapy and the drug cost of olaparib for people who remain on treatment after 15 months will be ...

Special report

Care of older people

Care of older people

Old age brings with it an increased likelihood of long-term conditions, as well as the prospect of taking multiple medicines. Frailty, dementia and mobility problems all contribute to the challenges faced by healthcare services when caring for ageing populations. Much can be done to improve the lives of older people – through innovative care pathways, evidence-based medicine and research into ageing and the delivery of care. Here, you can find news stories and articles on topics ranging from medication reviews in care homes to preventing falls in older people.

Read on

A reference you need

Introduction to Pharmaceutical Calculations

Together with its companion text Pharmaceutical Calculations Workbook, Introduction to Pharmaceutical Calculations is essential reading for pharmacy undergraduates and pre-registration pharmacists.

Order your copy

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.